Stephen Baxter
Stock Analyst at Wells Fargo
(3.20)
# 1,028
Out of 4,829 analysts
168
Total ratings
41.9%
Success rate
1.95%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Overweight | $76 → $84 | $66.97 | +25.43% | 14 | May 6, 2025 | |
| MCK McKesson | Maintains: Equal-Weight | $641 → $691 | $693.46 | -0.35% | 5 | Mar 14, 2025 | |
| COR Cencora | Maintains: Equal-Weight | $251 → $274 | $283.00 | -3.18% | 2 | Mar 14, 2025 | |
| OSCR Oscar Health | Downgrades: Equal-Weight | $20 → $16 | $17.11 | -6.49% | 10 | Mar 13, 2025 | |
| UHS Universal Health Services | Maintains: Overweight | $230 → $225 | $181.78 | +23.78% | 13 | Mar 10, 2025 | |
| CYH Community Health Systems | Maintains: Underweight | $2.5 → $2 | $3.50 | -42.86% | 8 | Mar 10, 2025 | |
| MOH Molina Healthcare | Upgrades: Overweight | $295 → $372 | $322.20 | +15.46% | 17 | Mar 5, 2025 | |
| CNC Centene | Maintains: Overweight | $76 → $72 | $62.79 | +14.67% | 21 | Feb 14, 2025 | |
| CI The Cigna Group | Maintains: Equal-Weight | $370 → $341 | $333.46 | +2.26% | 6 | Feb 4, 2025 | |
| CAH Cardinal Health | Maintains: Equal-Weight | $135 → $136 | $148.22 | -8.24% | 6 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $694 → $660 | $380.64 | +73.39% | 10 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $483 → $478 | $404.58 | +18.15% | 9 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $21 | $22.82 | -7.96% | 3 | Nov 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $205 → $150 | $148.83 | +0.79% | 12 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $400 → $320 | $353.70 | -9.53% | 13 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $387 → $290 | $249.53 | +16.22% | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $7.11 | +110.97% | 3 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $8 | $2.89 | +176.82% | 6 | Feb 26, 2024 |
CVS Health
May 6, 2025
Maintains: Overweight
Price Target: $76 → $84
Current: $66.97
Upside: +25.43%
McKesson
Mar 14, 2025
Maintains: Equal-Weight
Price Target: $641 → $691
Current: $693.46
Upside: -0.35%
Cencora
Mar 14, 2025
Maintains: Equal-Weight
Price Target: $251 → $274
Current: $283.00
Upside: -3.18%
Oscar Health
Mar 13, 2025
Downgrades: Equal-Weight
Price Target: $20 → $16
Current: $17.11
Upside: -6.49%
Universal Health Services
Mar 10, 2025
Maintains: Overweight
Price Target: $230 → $225
Current: $181.78
Upside: +23.78%
Community Health Systems
Mar 10, 2025
Maintains: Underweight
Price Target: $2.5 → $2
Current: $3.50
Upside: -42.86%
Molina Healthcare
Mar 5, 2025
Upgrades: Overweight
Price Target: $295 → $372
Current: $322.20
Upside: +15.46%
Centene
Feb 14, 2025
Maintains: Overweight
Price Target: $76 → $72
Current: $62.79
Upside: +14.67%
The Cigna Group
Feb 4, 2025
Maintains: Equal-Weight
Price Target: $370 → $341
Current: $333.46
Upside: +2.26%
Cardinal Health
Feb 4, 2025
Maintains: Equal-Weight
Price Target: $135 → $136
Current: $148.22
Upside: -8.24%
Jan 28, 2025
Maintains: Overweight
Price Target: $694 → $660
Current: $380.64
Upside: +73.39%
Jan 28, 2025
Maintains: Overweight
Price Target: $483 → $478
Current: $404.58
Upside: +18.15%
Nov 27, 2024
Maintains: Overweight
Price Target: $17 → $21
Current: $22.82
Upside: -7.96%
Nov 25, 2024
Downgrades: Equal-Weight
Price Target: $205 → $150
Current: $148.83
Upside: +0.79%
Nov 25, 2024
Downgrades: Underweight
Price Target: $400 → $320
Current: $353.70
Upside: -9.53%
Nov 4, 2024
Maintains: Overweight
Price Target: $387 → $290
Current: $249.53
Upside: +16.22%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $7.11
Upside: +110.97%
Feb 26, 2024
Maintains: Overweight
Price Target: $16 → $8
Current: $2.89
Upside: +176.82%